Search by Drug Name or NDC

    NDC 00574-2415-65 Methylphenidate Transdermal System 41.3 mg/mg Details

    Methylphenidate Transdermal System 41.3 mg/mg

    Methylphenidate Transdermal System is a TRANSDERMAL PATCH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PADAGIS US LLC. The primary component is METHYLPHENIDATE.

    Product Information

    NDC 00574-2415
    Product ID 0574-2415_134a3034-e670-488c-99d1-a482109b0a2d
    Associated GPIs
    GCN Sequence Number 060616
    GCN Sequence Number Description methylphenidate PATCH TD24 15MG/9HR TRANSDERM
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 26802
    HICL Sequence Number 033556
    HICL Sequence Number Description METHYLPHENIDATE
    Brand/Generic Generic
    Proprietary Name Methylphenidate Transdermal System
    Proprietary Name Suffix n/a
    Non-Proprietary Name methylphenidate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form PATCH
    Route TRANSDERMAL
    Active Ingredient Strength 41.3
    Active Ingredient Units mg/mg
    Substance Name METHYLPHENIDATE
    Labeler Name PADAGIS US LLC
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021514
    Listing Certified Through 2024-12-31

    Package

    NDC 00574-2415-65 (00574241565)

    NDC Package Code 0574-2415-65
    Billing NDC 00574241565
    Package 1 TRAY in 1 CARTON (0574-2415-65) / 30 POUCH in 1 TRAY / 1 PATCH in 1 POUCH / 41.3 mg in 1 PATCH
    Marketing Start Date 2023-06-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 11.1512
    Pricing Unit EA
    Effective Date 2023-12-20
    NDC Description METHYLPHENIDATE 15 MG/9 HR PATCH
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis